Nalaganje...
Discovery of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform p110α
p110α (PIK3CA) is the most frequently mutated kinase in human cancer, and numerous drugs targeting this kinase are currently in pre-clinical development or early stage clinical trials. Clinical resistance to protein kinase inhibitors frequently results from point mutations that block drug binding; s...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2008
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2720137/ https://ncbi.nlm.nih.gov/pubmed/18691552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2008.06.014 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|